‘Regen ag’ is all the rage, but it’s not going to fix our food system

Its being touted by companies, but other schools of thought are being pushed to the margins as a consequence

Decades of industrial agriculture has had its costs. Soils have deteriorated and plant and animal species are disappearing. Landscapes are degraded and small-scale farmers are struggling. It’s little wonder we’re looking for more sustainable and just ways of growing food and fibre. Regenerative agriculture is one alternative creating a lot of buzz, especially in rich,

(Bayer.com)

Bayer under investor pressure to speed up CEO changeover

Drug and chem firm's stock in 'crisis of trust,' investor says

Frankfurt | Reuters — A top-10 shareholder in Bayer on Tuesday called on the group’s supervisory board to replace CEO Werner Baumann quickly, adding to investor pressure to restore trust and revive the German drugmaker’s sagging share price. Despite recent improvements in the company’s agriculture business and drug development prospects, Bayer shares have been weighed


Bayer sued for barring non-U.S. citizen from Roundup settlement

Reuters – A new U.S. lawsuit accuses Bayer of illegally excluding a Virginia farm worker from a settlement over claims its Roundup herbicide causes cancer because she is not a U.S. citizen. The complaint said Elvira Reyes-Hernandez, who used Roundup while working on tree farms before being diagnosed with non-Hodgkin’s lymphoma in 2019, expected to

Bayer’s cross symbol hangs in a terminal at Frankfurt International Airport. (Typhoonski/iStock Editorial/Getty Images)

Activist investor reported building stake in Bayer, seeking breakup

Bayer up for 'constructive dialogue'

Reuters — Activist investor Bluebell Capital Partners has built a stake in Bayer AG and is pushing for a breakup of the German pharmaceutical and agriculture company, Bloomberg reported on Tuesday, citing sources. U.K.-based Bluebell is also seeking an overhaul of Bayer’s corporate governance, the report added. A Bayer spokesperson, who declined to comment on


Weedkiller windfall helps Bayer top profit forecasts

Reuters – Bayer has reported better-than-expected quarterly earnings as a temporary price boost for its glyphosate-based herbicides made up for a decline in sales of its stroke prevention pill Xarelto. The German company said third-quarter adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) rose 17.3 per cent to US$2.45 billion, above analysts’ average estimate

(Bayer.com)

Bayer’s agriculture unit, consumer health drive outlook hike

Frankfurt | Reuters – Agriculture and pharmaceuticals company Bayer BAYGn.DE on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and higher sales of consumer health products. Bayer is now targeting earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special items, of about 13 billion



The U.S. Supreme Court building in Washington, June 27, 2022.  Photo: Reuters/Elizabeth Frantz

U.S. Supreme Court again nixes Bayer challenge to weedkiller suits

Washington | Reuters – The U.S. Supreme Court on Monday rejected another Bayer AG BAYGn.DE bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower